GlassScriptPhysician profile
Fred W Ruymann
NPI 1568466316
$7,725.76
in general payments reported to CMS, 2019-2025
35 companies · $1,582 in 2025
The $1,582 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $208 · 2020: $391 · 2021: $802 · 2022: $1,211 · 2023: $1,670 · 2024: $1,861 · 2025: $1,582.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,014 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,014.23 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,856.01 | 2020-2025 | Skyrizi, Rinvoq, Linzess |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $869.72 | 2021-2025 | Xifaxan |
| Janssen Biotech, INC. | $830.20 | 2019-2025 | Stelara, Tremfya |
| Takeda Pharmaceuticals U.S.A., INC. | $685.26 | 2019-2025 | Entyvio |
| Braintree Laboratories, INC. | $395.42 | 2019-2025 | Sutab |
| Ferring Pharmaceuticals INC. | $352.74 | 2021-2025 | Rebyota |
| Olympus America INC. | $280.43 | 2020-2025 | Visiglide, Single Use Repositionable Clip, Olympus Endotherapy Inflation Device For Endoscopic Balloon Dilation |
| Boston Scientific Corporation | $260.41 | 2020-2023 | Resolution 360 Clip, Exalt Model D |
| Aimmune Therapeutics, INC. | $252.89 | 2025 | Vowst, Zenpep |
| Phathom Pharmaceuticals, INC. | $244.14 | 2023-2025 | Voquezna |
| Nestle Healthcare Nutrition INC. | $229.39 | 2021-2023 | |
| Janssen Scientific Affairs, LLC | $226.79 | 2022 | |
| Madrigal Pharmaceuticals | $190.42 | 2024-2025 | Rezdiffra, Resmetirom |
| Cook Medical LLC | $163.94 | 2022-2023 | Fusion |
| Ardelyx, INC. | $108.78 | 2023-2024 | Ibsrela |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $107.75 | 2021-2024 | |
| Genzyme Corporation | $99.01 | 2023-2025 | |
| Csl Behring | $67.93 | 2020-2021 | |
| Ironwood Pharmaceuticals, INC | $64.10 | 2023-2024 | Linzess |
| Shire North American Group INC | $46.22 | 2019 | |
| Lilly USA, LLC | $38.02 | 2024 | Omvoh |
| Amgen INC. | $36.68 | 2025 | Uplizna |
| Merck Sharp & Dohme LLC | $33.92 | 2022-2023 | Dificid |
| Allergan, INC. | $33.01 | 2019 | |
| Acera Surgical, INC. | $31.21 | 2024 | Restrata Wound Matrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.44 | 2023 | Cyltezo |
| Regeneron Healthcare Solutions, INC. | $26.28 | 2025 | Dupixent |
| Kci USA, INC. | $24.97 | 2023 | V.A.C. Veraflo Cleanse Choice, Prevena |
| Heron Therapeutics, INC. | $22.96 | 2023 | Zynrelef |
| Myriad Genetic Laboratories, INC. | $22.41 | 2023 | Myrisk |
| Intercept Pharmaceuticals, INC. | $21.26 | 2019 | |
| Acell, INC. | $20.82 | 2019 | |
| Lucid Diagnostics INC. | $19.69 | 2025 | |
| Ambu INC. | $16.68 | 2021 | |
| Fujifilm Healthcare Americas Corporation | $15.86 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fred Ruymann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.